Segall Bryant & Hamill LLC Trims Stock Position in RadNet, Inc. $RDNT

Segall Bryant & Hamill LLC cut its position in RadNet, Inc. (NASDAQ:RDNTFree Report) by 4.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 301,812 shares of the medical research company’s stock after selling 15,660 shares during the quarter. Segall Bryant & Hamill LLC owned about 0.38% of RadNet worth $16,868,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of the company. AQR Capital Management LLC increased its stake in RadNet by 5.4% in the 1st quarter. AQR Capital Management LLC now owns 6,846 shares of the medical research company’s stock worth $340,000 after acquiring an additional 350 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of RadNet by 4.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 39,341 shares of the medical research company’s stock valued at $1,956,000 after acquiring an additional 1,699 shares during the last quarter. Jones Financial Companies Lllp boosted its position in shares of RadNet by 563.4% during the 1st quarter. Jones Financial Companies Lllp now owns 1,705 shares of the medical research company’s stock valued at $85,000 after acquiring an additional 1,448 shares during the last quarter. United Services Automobile Association purchased a new position in shares of RadNet during the first quarter worth about $216,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of RadNet by 2.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 440,543 shares of the medical research company’s stock worth $21,904,000 after purchasing an additional 8,762 shares in the last quarter. 77.90% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Jefferies Financial Group reissued a “buy” rating on shares of RadNet in a report on Friday. Zacks Research lowered RadNet from a “hold” rating to a “strong sell” rating in a research note on Monday, July 13th. Weiss Ratings lowered RadNet from a “sell (d)” rating to a “sell (d-)” rating in a research report on Tuesday, May 12th. Finally, Barclays dropped their target price on RadNet from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Wednesday, May 20th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $87.43.

Check Out Our Latest Analysis on RDNT

Insider Buying and Selling

In related news, CEO Cornelis Wesdorp sold 4,750 shares of the business’s stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $58.11, for a total value of $276,022.50. Following the sale, the chief executive officer directly owned 69,075 shares in the company, valued at approximately $4,013,948.25. The trade was a 6.43% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director David L. Swartz sold 2,699 shares of the stock in a transaction on Thursday, June 18th. The shares were sold at an average price of $53.89, for a total transaction of $145,449.11. Following the transaction, the director owned 177,013 shares of the company’s stock, valued at $9,539,230.57. This trade represents a 1.50% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 5.60% of the company’s stock.

RadNet Price Performance

RDNT opened at $63.78 on Friday. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.17 and a quick ratio of 1.17. The firm has a market cap of $5.02 billion, a PE ratio of -354.31 and a beta of 1.37. RadNet, Inc. has a 1 year low of $50.76 and a 1 year high of $85.84. The stock has a 50-day moving average price of $59.54 and a 200-day moving average price of $61.89.

RadNet (NASDAQ:RDNTGet Free Report) last issued its earnings results on Monday, May 11th. The medical research company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.14). RadNet had a positive return on equity of 2.77% and a negative net margin of 0.66%.The business had revenue of $575.63 million during the quarter, compared to analysts’ expectations of $557.93 million. During the same period last year, the firm posted ($0.50) EPS. RadNet’s quarterly revenue was up 22.1% compared to the same quarter last year. Sell-side analysts predict that RadNet, Inc. will post 0.54 earnings per share for the current fiscal year.

RadNet Company Profile

(Free Report)

RadNet, Inc is a leading independent provider of outpatient diagnostic imaging services in the United States. Through a nationwide network of fixed-site imaging centers and affiliated joint-venture locations, the company delivers a comprehensive suite of radiology services including MRI, CT, PET/CT, ultrasound, X-ray, mammography, bone densitometry, nuclear medicine and interventional radiology procedures. RadNet also offers teleradiology and imaging management solutions to physician practices, hospitals and healthcare systems.

Founded in 1981 and headquartered in Los Angeles, RadNet has expanded its footprint organically and through strategic acquisitions.

Featured Stories

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.